1. European Medicines Agency. COVID-19 vaccines: authorised [Internet]. [cited 2024 Mar 21]. Available from: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#covid-19-vaccines:-strains,-use-and-age-ranges-(new)-section.
2. European Centre for Disease Prevention and Control. EMA and ECDC statement on updating COVID-19 vaccines to target new SARS-CoV-2 virus variants [Internet]. [cited 2024 Feb 12]. Available from: file:///C:/Users/esthe/Downloads/ecdc-ema_statement_on_updating_covid-19_vaccines_composition_for_new_sars-cov-2_virus_variants_en(1).pdf.
3. European Centre for Disease Prevention and Control. Interim COVID-19 vaccination coverage in the EU/EEA during the 2023–24 season campaigns [Internet]. 2024 Jan [cited 2024 Apr 19]. Available from: https://www.ecdc.europa.eu/sites/default/files/documents/interim-vaccine-overage-eu-eea-2023-24.pdf.
4. European Centre for Disease Prevention and Control. European Respiratory Virus Surveillance Summary (ERVISS), 2024, Week 07. [Internet]. 202Available from: https://erviss.org/.
5. I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines;Valenciano;Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull,2012